Enovis Gross Profit 2010-2024 | ENOV
Enovis gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Enovis Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $991 |
| 2022 | $869 |
| 2021 | $778 |
| 2020 | $604 |
| 2019 | $1,401 |
| 2018 | $729 |
| 2017 | $672 |
| 2016 | $992 |
| 2015 | $1,072 |
| 2014 | $1,479 |
| 2013 | $1,306 |
| 2012 | $1,152 |
| 2011 | $240 |
| 2010 | $191 |
| 2009 | $186 |
| Enovis Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $286 |
| 2024-06-30 | $289 |
| 2024-03-31 | $298 |
| 2023-12-31 | $264 |
| 2023-09-30 | $243 |
| 2023-06-30 | $248 |
| 2023-03-31 | $235 |
| 2022-12-31 | $232 |
| 2022-09-30 | $216 |
| 2022-06-30 | $216 |
| 2022-03-31 | $206 |
| 2021-12-31 | $8 |
| 2021-09-30 | $198 |
| 2021-06-30 | $201 |
| 2021-03-31 | $371 |
| 2020-12-31 | $-330 |
| 2020-09-30 | $344 |
| 2020-06-30 | $241 |
| 2020-03-31 | $348 |
| 2019-12-31 | $396 |
| 2019-09-30 | $368 |
| 2019-06-30 | $376 |
| 2019-03-31 | $261 |
| 2018-12-31 | $96 |
| 2018-09-30 | $171 |
| 2018-06-30 | $192 |
| 2018-03-31 | $271 |
| 2017-12-31 | $-90 |
| 2017-09-30 | $264 |
| 2017-06-30 | $258 |
| 2017-03-31 | $240 |
| 2016-12-31 | $172 |
| 2016-09-30 | $238 |
| 2016-06-30 | $301 |
| 2016-03-31 | $281 |
| 2015-12-31 | $153 |
| 2015-09-30 | $296 |
| 2015-06-30 | $328 |
| 2015-03-31 | $294 |
| 2014-12-31 | $392 |
| 2014-09-30 | $373 |
| 2014-06-30 | $388 |
| 2014-03-31 | $326 |
| 2013-12-31 | $357 |
| 2013-09-30 | $320 |
| 2013-06-30 | $338 |
| 2013-03-31 | $291 |
| 2012-12-31 | $308 |
| 2012-09-30 | $288 |
| 2012-06-30 | $315 |
| 2012-03-31 | $242 |
| 2011-12-31 | $62 |
| 2011-09-30 | $61 |
| 2011-06-30 | $65 |
| 2011-03-31 | $53 |
| 2010-12-31 | $60 |
| 2010-09-30 | $47 |
| 2010-06-30 | $43 |
| 2010-03-31 | $42 |
| 2009-12-31 | $47 |
| 2009-09-30 | $46 |
| 2009-06-30 | $45 |
| 2009-03-31 | $48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.529B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Standard BioTools (LAB) | United States | $0.562B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |